{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:54:48Z","timestamp":1761548088192,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.hrthm.2020.06.013","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T19:24:25Z","timestamp":1592076265000},"page":"1951-1952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["About the different faces of mexiletine"],"prefix":"10.1016","volume":"17","author":[{"given":"Pieter G.","family":"Postema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.06.013_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01628342","article-title":"Vergleichende Untersuchungen zur Lehre von der Muskel-und Nervenelektricitat","volume":"15","author":"Engelmann","year":"1877","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.hrthm.2020.06.013_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(73)92270-8","article-title":"Treatment of ventricular arrhythmias with mexiletine (K\u00f6 1173)","volume":"2","author":"Talbot","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2020.06.013_bib3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(80)92395-8","article-title":"Oral mexiletine in high-risk patients after myocardial infarction","volume":"2","author":"Chamberlain","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2020.06.013_bib4","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.06.013_bib5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.06.013_bib6","first-page":"1601","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.06.013_bib7","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.06.013_bib8","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1001\/jama.2018.18020","article-title":"Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials","volume":"320","author":"Stunnenberg","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2020.06.013_bib9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2020.06.013_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpainsymman.2007.04.022","article-title":"Mexiletine therapy for chronic pain: survival analysis identifies factors predicting clinical success","volume":"35","author":"Carroll","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.hrthm.2020.06.013_bib11","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.hrthm.2020.05.043","article-title":"Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up","volume":"17","author":"Vio","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.06.013_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.06.013_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(18)31069-9","article-title":"Outrageous prices of orphan drugs: a call for collaboration","volume":"392","author":"Luzzatto","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2020.06.013_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/eurheartj\/ehaa041","article-title":"Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine","volume":"41","author":"Postema","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120305555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120305555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:51:13Z","timestamp":1761547873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120305555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547527120305555"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.06.013","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"About the different faces of mexiletine","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.043","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}